Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) announced its quarterly earnings results on Thursday. Aldeyra Therapeutics Trading Down 2.5%Shares of NASDAQ:ALDX traded down $0.04 on Friday, reaching $1.55. Get Aldeyra Therapeutics alerts:Wall Street Analyst Weigh InA number of brokerages have recently weighed in on ALDX. Aldeyra Therapeutics Company Profile(Get Free Report)Aldeyra Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapies for immune-mediated diseases. Featured StoriesReceive News & Ratings for Aldeyra Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aldeyra Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.